1-3 of 3
Joseph R Mikhael, MD FRCPC, MD
Close
Sort by
Journal Articles

"Direct to Drug" Screening As a Route to Individualized Therapy in Multiple Myeloma

Nathalie Meurice, PhD, Joachim L Petit, PhD, Cecilia Bonolo De Campos, PhD, Alysia N Polito, BS, Ilsel D Lopez Armenta, BS, Gregory J Ahmann, BS, Laura Ann Bruins, BS, Joseph R Mikhael, MD FRCPC, MD, Craig B. Reeder, MD, Angela A Mayo, MS, PA-C, P. Leif Bergsagel, MD, Rafael Fonseca, MD, Nikolai Sepetov, PhD, Sergei Romanov, PhD, A. Keith Stewart, MBChB, MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3080.
https://doi.org/10.1182/blood.V130.Suppl_1.3080.3080
Published: 2017
Journal Articles

Duration Matters: Impact of Time from Diagnosis on Symptoms in Patients with Hematologic Malignancies

Leslie Padrnos, MD, Heidi Kosiorek, MS, Robert M Bennett, III, Amylou Constance Dueck, PhD, Krisstina L. Gowin, DO, Robyn M. Scherber, MD, Holly L. Geyer, MD, Jeanne Palmer, MD, Donald Northfelt, MD, Joseph R Mikhael, MD FRCPC, MD, Nandita Khera, MD, Ruben A Mesa, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2162.
https://doi.org/10.1182/blood.V130.Suppl_1.2162.2162
Published: 2017
Journal Articles

Diagnosing and Managing Plasma Cell Disorders: Education Gaps in Primary Care Providers and Hematologist/Oncologists

Emily S Van Laar, Robert Z. Orlowski, MD PhD, Davecia Cameron, MSc, Steven W Ressler, MD, Joseph R Mikhael, MD FRCPC, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5606.
https://doi.org/10.1182/blood.V130.Suppl_1.5606.5606
Published: 2017